Reblozyl 25 mg lyophilized powder for injection Images
Generic Name: luspatercept
This medication has been identified as Reblozyl 25 mg lyophilized powder for injection. It is supplied by Celgene Corporation.
Reblozyl is used in the treatment of Myelodysplastic Syndrome; Beta Thalassemia; Anemia and belongs to the drug class miscellaneous erythropoiesis agents. Reblozyl 25 mg lyophilized powder for injection is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Reblozyl
- Generic Name
- luspatercept
- Strength
- 25 mg lyophilized powder for injection
- Availability
- Prescription only
- Drug Class
- Miscellaneous erythropoiesis agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Celgene Corporation
- National Drug Code (NDC)
- 59572-0711
See also:
Procrit
Procrit is a man-made protein used to treat anemia caused by chronic kidney disease, chemotherapy ...
Vidaza
Vidaza is used to treat certain types of bone marrow cancers and blood cell disorders. Learn about ...
Tibsovo
Tibsovo (ivosidenib) is a once-daily oral medication that targets a specific gene mutation called ...
Dacogen
Dacogen (decitabine) is used to treat myelodysplastic syndromes (certain types of blood or bone ...
Inqovi
Inqovi (decitabine and cedazuridine) is used for the treatment of myelodysplastic syndromes (MDS) ...
Rytelo
Rytelo (imetelstat) is an injectable telomerase inhibitor that may be used to treat adults with ...
Onureg
Onureg (azacitidine) is used for the continued treatment of adult patients with acute myeloid ...
Cedazuridine/decitabine
Cedazuridine/decitabine is used for myelodysplastic syndrome
Decitabine
Decitabine is used for acute myeloid leukemia, myelodysplastic syndrome
More about Reblozyl (luspatercept)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (6)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: miscellaneous erythropoiesis agents
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.